Belite Bio
BLTE
11 hedge funds and large institutions have $8.52M invested in Belite Bio in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
282% more capital invested
Capital invested by funds: $2.23M → $8.52M (+$6.29M)
0.41% more ownership
Funds ownership: 0.2% → 0.61% (+0.41%)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$6.41M |
| 2 |
HF
HRT Financial
New York
|
+$234K |
| 3 |
GI
GAMMA Investing
Foster City,
California
|
+$8.4K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$130 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$406K |
| 2 |
Morgan Stanley
New York
|
-$218K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$184K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$70.2K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$60.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $6.76M | +$6.41M | +148,000 | New |
|
2
State Street
Boston,
Massachusetts
| $716K | -$43.2K | -999 | -6% |
|
|
3
Point72 Asset Management
Stamford,
Connecticut
| $334K | -$60.1K | -1,389 | -16% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $306K | – | – | – |
|
|
HF
5
HRT Financial
New York
| $247K | +$234K | +5,409 | New |
|
|
VEA
6
Virtus ETF Advisers
New York
| $82.5K | -$6.58K | -152 | -8% |
|
|
7
Morgan Stanley
New York
| $47.7K | -$218K | -5,046 | -83% |
|
|
GI
8
GAMMA Investing
Foster City,
California
| $19.6K | +$8.4K | +194 | +83% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $4.66K | -$70.2K | -1,622 | -94% |
|
10
JP Morgan Chase
New York
| $4.02K | -$24.7K | -570 | -87% |
|
|
11
Osaic Holdings
Scottsdale,
Arizona
| $365 | +$130 | +3 | +60% |
|
|
12
Marshall Wace
London,
United Kingdom
| – | -$406K | -10,584 | Closed |
|
|
CSS
13
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$184K | -4,788 | Closed |
|
BLTE Hedge Fund Activity: Q2 2024 in Review
11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q2 2024, worth a combined $8.52M — up 282% from $2.23M a quarter earlier.
Fund positioning in BLTE was balanced in Q2 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $6.41M. The largest seller was Marshall Wace, exiting entirely with an estimated $406K sold.
- 11 institutional investors held Belite Bio (BLTE) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $8.52M of Belite Bio stock for Q2 2024, up 282% quarter-over-quarter.
- 2 funds opened new Belite Bio positions in Q2 2024 and 2 closed out, a net change of 0 holders.
- The largest Belite Bio buyer in Q2 2024 was Armistice Capital, an estimated $6.41M added.
- The largest Belite Bio seller in Q2 2024 was Marshall Wace, an estimated $406K sold.
Based on aggregated 13F filings for Q2 2024.